Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-133215
Filing Date
2021-11-02
Accepted
2021-11-02 18:10:38
Documents
1
Period of Report
2021-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2131338-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2131338-3_4seq1.xml 4 3434
  Complete submission text file 0001104659-21-133215.txt   4801
Mailing Address C/O NYSE EURONEXT 11 WALL STREET NEW YORK NY 10005
Business Address
LEIBOWITZ LAWRENCE E (Reporting) CIK: 0001276505 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40949 | Film No.: 211372847

Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Issuer) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7372 Services-Prepackaged Software